
3D-Printed Brain Tissue Accelerates Alzheimer’s Research
The first 3D-printed brain tissue that can grow and function like typical brain tissue is a major breakthrough for scientists in search of an Alzheimer’s cure.
The first 3D-printed brain tissue that can grow and function like typical brain tissue is a major breakthrough for scientists in search of an Alzheimer’s cure.
Research shows that a blood test now on the market accurately identifies brain amyloid status with a single blood sample. In other words, this blood test can diagnose Alzheimer’s.
A massive study of medical and genetic data shows that people with a particular version of a gene involved in immune response had a lower risk of Alzheimer’s and Parkinson’s disease.
Scientists at Oregon’s only public academic health center (OHSU) have discovered a new avenue of cell death in Alzheimer’s disease and vascular dementia.
Tau PET is an imaging test used to detect the presence of tau protein in the brain. Researchers say it’s the best way to predict the rate of cognitive decline due to Alzheimer’s.
Dr. Robert Przybelski has prescribed lecanemab to real-life patients, and discusses his experience prescribing and administering the treatment.
Now, a third new Alzheimer’s drug expected to be approved by the Food and Drug Administration (FDA),. The field of new drugs is beginning to show progress in the fight to slow the disease.
The FDA has approved generic lecanemab (brand name Leqembi®). The new drug can slow the progression of Alzheimer’s. Two top doctors discuss the pros and cons.
The FDA Advisory Committee’s endorsement of Leqembi paves way for traditional approval, ushers in a new era for Alzheimer’s
A young Chinese prodigy determined to help his grandmother with Alzheimer’s invented an AI mini-computer to help her recognize family members and find the way home.
Once a week, a chorus of people with Alzheimer’s rehearse side-by-side with their caregivers. The songs they sing are, remarkably, often from memory. Watch “The Giving Voice Chorus” in action.
START WORLD ALZHEIMER’S MONTH WITH A HEALTHY DEMENTIA-FIGHTING INFOGRAPH & VIDEO.
Prevent dementia. Learn how to lower your Alzheimer’s risk. Be good to your brain this World Alzheimer’s Month.
They’re not just pills—they’re precision infusions designed to slow Alzheimer’s at its source. See UCLA’s cutting-edge Amyloid Immunotherapy Care Program, and what it feels like to begin treatment with Leqembi (lecanemab) and Kisunla (donanemab).
SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
No spam, only news and updates.